Schistosoma mansoni infection impairs antimalaria treatment and immune responses of rhesus macaques infected with mosquito-borne Plasmodium coatneyi

Infection and Immunity

Volumn 80, Issue 11, 2012, Pages 3821-3827

  Semenya, Amma A ^a   Sullivan, JoAnn S ^a   Barnwell, John W ^a   Secor, W Evan ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CYTOKINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; QUININE;

ANTIBODY RESPONSE; ARTICLE; ERYTHROCYTE; HEMATOCRIT; MALARIA; PARASITEMIA; PLASMODIUM; PLASMODIUM COATNEYI; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHESUS MONKEY; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIMALARIALS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; MACACA MULATTA; MALARIA; PARASITEMIA; PLASMODIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 84867615098     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00590-12     Document Type: Article

References (30)

1. Barnwell JW. 2006. Malaria: death and disappearing erythrocytes. Blood 107:854-855.
2. Briand V, Watier L, Le Hesran JY, Garcia A, Cot M. 2005. Coinfectionwith Plasmodium falciparum and Schistosoma haematobium: protective effect of schistosomiasis on malaria in Senegalese children? Am. J. Trop. Med. Hyg. 72:702-707.
3. Buck AA, Anderson RI, MacRae AA. 1978. Epidemiology of polyparasitism. II. Types of combinations, relative frequency and associations of multiple infections. Tropenmed. Parasitol. 29:137-144.
4. Buck AA, Anderson RI, MacRae AA. 1978. Epidemiology of polyparasitism. III. Effects on the diagnostic capacity of immunological tests. Tropenmed. Parasitol. 29:145-155.
5. Buck AA, Anderson RI, MacRae AA. 1978. Epidemiology of polyparasitism. IV. Combined effects on the state of health. Tropenmed. Parasitol.29:253-268.
6. Casals-Pascual C, Roberts DJ. 2006. Severe malarial anaemia. Curr. Mol.Med. 6:155-168.
7. Cohen S, McGregor IA, Carrington S. 1961. Gamma-globulin and acquired immunity to human malaria. Nature 192:733-737.
8. Craig AG, et al. 2012. The role of animal models for research on severe malaria. PLoS Pathog. 8:e1002401. doi:10.1371/journal.ppat.1002401.
9. Hartgers FC, Yazdanbakhsh M. 2006. Co-infection of helminths and malaria: modulation of the immune responses to malaria. Parasite Immunol.28:497-506.
10. Helmby H, Kullberg M, Troye-Blomberg M. 1998. Altered immune responses in mice with concomitant Schistosoma mansoni and Plasmodium chabaudi infections. Infect. Immun. 66:5167-5174.
11. Keusch GT, Migasena P. 1982. Biological implications of polyparasitism. Rev. Infect. Dis. 4:880-882.
12. King CH, Dangerfield-Cha M. 2008. The unacknowledged impact of chronic schistosomiasis. Chronic Illn. 4:65-79.
13. Laranjeiras RF, Brant LC, Lima AC, Coelho PM, Braga EM. 2008.Reduced protective effect of Plasmodium berghei immunization by concurrent Schistosoma mansoni infection. Mem. Inst. Oswaldo Cruz 103: 674-677.
14. Legesse M, Erko B, Balcha F. 2004. Increased parasitaemia and delayed parasite clearance in Schistosoma mansoni and Plasmodium berghei coinfected mice. Acta Trop. 91:161-166.
15. Lyke KE, et al. 2005. Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children. Am. J. Trop. Med. Hyg. 73:1124 -1130.
16. Mcgregor IA. 1964. The passive transfer of human malarial immunity. Am. J. Trop. Med. Hyg. 13:237-239.
17. Nookala S, Srinivasan S, Kaliraj P, Narayanan RB, Nutman TB. 2004. Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis. Infect. Immun. 72: 2598-2604.
18. Reilly L, Magkrioti C, Mduluza T, Cavanagh DR, Mutapi F. 2008. Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses. BMC Infect. Dis. 8:158.
19. Sabin EA, Araujo MI, Carvalho EM, Pearce EJ. 1996. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J. Infect. Dis. 173:269 -272.
20. Sangweme D, Shiff C, Kumar N. 2009. Plasmodium yoelii: adverse outcome of non-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse model. Exp. Parasitol. 122:254 -259.
21. Sangweme DT, et al. 2010. Impact of schistosome infection on Plasmodium falciparum malariometric indices and immune correlates in school age children in Burma Valley, Zimbabwe. PLoS Negl. Trop. Dis. 4:e882. doi:10.1371/journal.pntd.0000882.
22. Secor WE. 2005. Immunology of human schistosomiasis: off the beaten path. Parasite Immunol. 27:309 -316.
23. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214 -217.
24. Sokhna C, et al. 2004. Increase of malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal. Malar. J. 3:43.
25. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. 2006. Schistosomiasis and water resources development: systematic review, metaanalysis, and estimates of people at risk. Lancet Infect. Dis. 6:411-425.
26. Supali T, et al. 2010. Polyparasitism and its impact on the immune system. Int. J. Parasitol. 40:1171-1176.
27. Verani JR, et al. 2011. Schistosomiasis among young children in Usoma,Kenya. Am. J. Trop. Med. Hyg. 84:787-791.
28. WHO. 2010. World health report. World Health Organization, Geneva,Switzerland.
29. Wilson S, Vennervald BJ, Dunne DW. 2011. Chronic hepatosplenomegaly in African school children: a common but neglected morbidity associated with schistosomiasis and malaria. PLoS Negl. Trop. Dis. 5:e1149.doi:10.1371/journal.pntd.0001149.
30. Wilson S, et al. 2010. Health implications of chronic hepatosplenomegaly in Kenyan school-aged children chronically exposed to malarial infections and Schistosoma mansoni. Trans. R. Soc. Trop. Med. Hyg. 104:110 -116.